Eli Lilly and Aktie
412,40
EUR
+8,00
EUR
+1,98
%
442,00
USD
-0,16
USD
-0,04
%
Eli Lilly and Aktie Analyse
| 05.10.18 | Eli Lilly and Outperform | BMO Capital Markets | |
| 25.07.18 | Eli Lilly and Neutral | Goldman Sachs Group Inc. | |
| 08.06.18 | Eli Lilly and Overweight | Cantor Fitzgerald | |
| 13.04.18 | Eli Lilly and Market Perform | BMO Capital Markets | |
| 16.01.18 | Eli Lilly and buy | Jefferies & Company Inc. | |
| 27.04.17 | Eli Lilly and Hold | Argus Research Company | |
| 21.04.17 | Eli Lilly and Underperform | BMO Capital Markets | |
| 07.04.17 | Eli Lilly and overweight | Barclays Capital | |
|
Werbung
|
|||
| 20.03.17 | Eli Lilly and Neutral | UBS AG | |
| 07.12.15 | Eli Lilly and Buy | Deutsche Bank AG | |
| 01.12.15 | Eli Lilly and overweight | Barclays Capital | |
| 20.11.15 | Eli Lilly and Outperform | BMO Capital Markets | |
| 22.07.15 | Eli Lilly and Equal weight | Barclays Capital | |
| 18.06.15 | Eli Lilly and Buy | Argus Research Company | |
| 08.01.15 | Eli Lilly and Hold | Deutsche Bank AG | |
| 08.01.15 | Eli Lilly and Neutral | UBS AG | |
| 02.07.14 | Eli Lilly and Equal weight | Barclays Capital | |
| 03.07.13 | Eli Lilly and kaufen | Citigroup Corp. | |
| 28.05.13 | Eli Lilly and halten | Jefferies & Company Inc. | |
| 03.12.12 | Eli Lilly and buy | Citigroup Corp. | |
| 13.11.12 | Eli Lilly and outperform | Credit Suisse Group | |
| 15.10.12 | Eli Lilly and underperform | Jefferies & Company Inc. | |
| 10.10.12 | Eli Lilly and neutral | Goldman Sachs Group Inc. | |
| 09.10.12 | Eli Lilly and neutral | UBS AG | |
| 01.10.12 | Eli Lilly and neutral | UBS AG | |
| 01.10.12 | Eli Lilly and kaufen | Die Actien-Börse | |
| 21.09.12 | Eli Lilly and neutral | UBS AG | |
| 06.09.12 | Eli Lilly and outperform | Sanford C. Bernstein and Co., Inc. | |
| 28.08.12 | Eli Lilly and neutral | UBS AG | |
| 28.08.12 | Eli Lilly and outperform | Credit Suisse Group | |
| 01.08.12 | Eli Lilly and neutral | Credit Suisse Group | |
| 31.07.12 | Eli Lilly and neutral | JP Morgan Chase & Co. | |
| 21.06.12 | Eli Lilly and neutral | Credit Suisse Group | |
| 12.01.12 | Eli Lilly and neutral | UBS AG | |
| 10.01.12 | Eli Lilly and hold | Jefferies & Company Inc. | |
| 27.10.11 | Eli Lilly and neutral | Citigroup Corp. | |
| 15.09.11 | Eli Lilly and overweight | Barclays Capital | |
| 25.07.11 | Eli Lilly and neutral | UBS AG | |
| 19.07.11 | Eli Lilly and hold | Citigroup Corp. | |
| 12.07.11 | Eli Lilly and hold | Citigroup Corp. | |
| 30.06.11 | Eli Lilly and hold | Citigroup Corp. | |
| 01.06.11 | Eli Lilly and hold | Citigroup Corp. | |
| 30.05.11 | Eli Lilly and equal-weight | Barclays Capital | |
| 16.05.11 | Eli Lilly and kaufen | Die Actien-Börse | |
| 20.04.11 | Eli Lilly and equal-weight | Barclays Capital | |
| 15.04.11 | Eli Lilly and equal-weight | Barclays Capital | |
| 07.03.11 | Eli Lilly and equal-weight | Barclays Capital | |
| 31.01.11 | Eli Lilly and equal-weight | Barclays Capital | |
| 13.01.11 | Eli Lilly and equal-weight | Barclays Capital | |
| 12.01.11 | Eli Lilly and hold | Citigroup Corp. | |